RLMD
Relmada Therapeutics, Inc. · Healthcare
CEO Sergio Traversa bought $395K of Relmada Therapeutics, Inc.
Bought$395,115
$2.82Price
140,000Shares
+57%Stake
What RLMD did for a copier
- $1,000 copied at Wed, Sep 11 close, $3.02
- $1,190
- S&P 500, same days
- +4.6%
Measured over 30 trading days, to the Oct 23 close.
Sergio Traversa's record
6 other buys with 3 months of prices since 2022: on average +81.4% against the S&P 500, and 3 of 6 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Sep 9. Filed Wed, Sep 11, 1:47 PM ET, during the session. Returns use the Sep 11 close and the Oct 23 close. Not investment advice.